v3.26.3
Supplemental Financial Information (Disaggregation Of Net Sales By Major Source) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 04, 2026
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Dec. 27, 2025
Concentration Risk [Line Items]            
Total net sales   $ 105,104 $ 42,234 $ 319,841 $ 112,915  
Deferred revenue   258,000   258,000    
Deferred Revenue, Current           $ 30,600
Deferred revenue, advances on product orders, current   30,500   30,500    
Patent License Agreement            
Concentration Risk [Line Items]            
Total net sales $ 32,900 200,000        
Net product sales            
Concentration Risk [Line Items]            
Total net sales   60,194 $ 42,234 274,931 $ 112,915  
License fee            
Concentration Risk [Line Items]            
Total net sales   $ 44,910   $ 44,910